Analysts expect Medline Inc. to report revenue of 7.98 B for Q3 26, against a range of 7.30 B to 8.65 B. The most recent reported quarter, Q2 26, came in at 7.68 B, a 3.9% miss against the 8.00 B consensus.
| Metric | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 7.12 B | 7.79 B | 7.35 B | 7.68 B | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | - | 7.44 B | 7.35 B | 8.25 B | 8.65 B | 9.19 B | 9.01 B | 8.13 B | 8.59 B | 9.01 B | 9.51 B | 9.78 B | ||||||||||
| Low Estimate | - | 7.00 B | 6.16 B | 7.74 B | 7.30 B | 8.36 B | 7.72 B | 7.57 B | 7.33 B | 8.29 B | 8.22 B | 8.65 B | ||||||||||
| Consensus Estimate | - | 7.22 B | 6.76 B | 8.00 B | 7.98 B | 8.78 B | 8.37 B | 7.85 B | 7.96 B | 8.65 B | 8.86 B | 9.22 B |
Analysts expect Medline Inc. to report earnings per share of 0.33 for Q3 26, against a range of 0.31 to 0.35. The most recent reported quarter, Q2 26, came in at 0.50, a 47.1% beat against the 0.34 consensus.
| Metric | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.31 | 0.22 | 0.33 | 0.50 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | - | 0.27 | 0.34 | 0.37 | 0.35 | 0.47 | 0.35 | 0.41 | 0.37 | 0.45 | 0.45 | 0.48 | ||||||||||
| Low Estimate | - | 0.23 | 0.30 | 0.31 | 0.31 | 0.39 | 0.33 | 0.37 | 0.31 | 0.39 | 0.41 | 0.42 | ||||||||||
| Consensus Estimate | - | 0.25 | 0.32 | 0.34 | 0.33 | 0.43 | 0.34 | 0.39 | 0.34 | 0.42 | 0.43 | 0.45 |